NORBERT G RIEDEL Insider Trading $JAZZ Jazz Pharmaceuticals plc
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for NORBERT G RIEDEL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of NORBERT G RIEDEL. NORBERT G RIEDEL is Corporate Vice President in BAXTER INTERNATIONAL INC ($BAX) and Senior Vice President in BAXTER INTERNATIONAL INC ($BAX) and Director in ARIAD PHARMACEUTICALS INC ($ARIA) and Director in Jazz Pharmaceuticals plc ($JAZZ) and CEO in Aptinyx Inc. ($APTX) and CEO and President in Aptinyx Inc. ($APTX) and Director in Eton Pharmaceuticals, Inc. ($ETON) and Director in Cerevel Therapeutics Holdings, Inc. ($ARYB).
NORBERT G RIEDEL in Jazz Pharmaceuticals plc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of NORBERT G RIEDEL: Director
Holdings: 10,390 shares
Current Value: $1,299,270
Latest Transaction: Aug 10 2020
$JAZZ Market Capitalization: $7.62B
$JAZZ Previous Close: $125.05
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of NORBERT G RIEDEL in Jazz Pharmaceuticals plc
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, APTX, ARIA, BAX, CERE, ETON, JAZZ
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 10 2020 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Option Exercise | A | 127.07 | 6,765 | 859,629 | 6,765 | |
| Aug 10 2020 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Sell | S | 125.87 | 931 | 117,186 | 9,459 | 10.4 K to 9.5 K (-8.96 %) |
| Aug 10 2020 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Grant | A | 0.00 | 2,705 | 0 | 10,390 | 7.7 K to 10.4 K (+35.20 %) |
| Aug 12 2019 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Option Exercise | A | 137.12 | 4,805 | 658,862 | 4,805 | |
| Aug 12 2019 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Sell | S | 135.65 | 726 | 98,482 | 7,685 | 8.4 K to 7.7 K (-8.63 %) |
| Aug 12 2019 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Grant | A | 0.00 | 1,920 | 0 | 8,411 | 6.5 K to 8.4 K (+29.58 %) |
| Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Option Exercise | A | 177.73 | 3,735 | 663,822 | 3,735 | |
| Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Sell | S | 176.61 | 660 | 116,563 | 6,491 | 7.2 K to 6.5 K (-9.23 %) |
| Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Grant | A | 0.00 | 1,495 | 0 | 7,151 | 5.7 K to 7.2 K (+26.43 %) |
| Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Option Exercise | A | 177.73 | 3,735 | 663,822 | 3,735 | |
| Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Sell | S | 176.61 | 660 | 116,563 | 6,491 | 7.2 K to 6.5 K (-9.23 %) |
| Aug 13 2018 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Grant | A | 0.00 | 1,495 | 0 | 7,151 | 5.7 K to 7.2 K (+26.43 %) |
| Aug 14 2017 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Option Exercise | A | 143.66 | 3,415 | 490,599 | 3,415 | |
| Aug 14 2017 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Sell | S | 144.13 | 3 | 432 | 5,656 | 5.7 K to 5.7 K (-0.05 %) |
| Aug 14 2017 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Sell | S | 142.36 | 659 | 93,815 | 5,659 | 6.3 K to 5.7 K (-10.43 %) |
| Aug 14 2017 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Grant | A | 0.00 | 1,365 | 0 | 6,318 | 5 K to 6.3 K (+27.56 %) |
| Aug 17 2016 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Sell | S | 136.45 | 633 | 86,373 | 4,953 | 5.6 K to 5 K (-11.33 %) |
| Aug 15 2016 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Option Exercise | A | 138.08 | 3,415 | 471,543 | 3,415 | |
| Aug 15 2016 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Grant | A | 0.00 | 1,365 | 0 | 5,586 | 4.2 K to 5.6 K (+32.34 %) |
| May 17 2016 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Sell | S | 145.20 | 644 | 93,509 | 4,221 | 4.9 K to 4.2 K (-13.24 %) |
| Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Option Exercise | A | 181.79 | 3,415 | 620,813 | 3,415 | |
| Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Sell | S | 183.36 | 4 | 733 | 4,865 | 4.9 K to 4.9 K (-0.08 %) |
| Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Sell | S | 179.98 | 797 | 143,444 | 4,869 | 5.7 K to 4.9 K (-14.07 %) |
| Aug 11 2015 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Grant | A | 0.00 | 1,310 | 0 | 5,666 | 4.4 K to 5.7 K (+30.07 %) |
| May 14 2015 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Sell | S | 175.10 | 6 | 1,051 | 4,356 | 4.4 K to 4.4 K (-0.14 %) |
| May 14 2015 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Sell | S | 173.85 | 644 | 111,959 | 4,362 | 5 K to 4.4 K (-12.86 %) |
Page: 1